| 14.99 Data as of 4:07pm ET |  +0.43 / +2.95%Today’s Change | 12.50 Today|||52-Week Range 16.99 | -6.55% Year-to-Date |
| Previous close | 14.56 |
| Today’s open | 14.60 |
| Day’s range | 14.54 - 15.07 |
| Volume | 83,572 |
| Average volume (3 months) | 213,197 |
| Market cap | $525.9M |
| Dividend yield | -- |
| Earnings growth (last year) | +1.56% |
| Earnings growth (this year) | +13.85% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +3.11% |
| P/E ratio | 24.2 |
| Price/Sales | 2.05 |
| Price/Book | 1.18 |
| Today’s change | Today’s % change | |
|---|---|---|
| CMRXChimerix Inc | +0.75 | +3.64% |
| CCXIChemoCentryx Inc | -0.02 | -0.16% |
| NLNKNewLink Genetics Cor... | +0.32 | +1.50% |
| ICPTIntercept Pharmaceut... | +0.20 | +0.61% |
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | $0.21 |
| Annual revenue (last year) | $281.9M |
| Annual profit (last year) | $23.5M |
| Net profit margin | 8.35% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Daniel J. Abdun-Nabi |
CFO, Treasurer & Executive VP-Corporate Services Robert G. Kramer, Sr., MBA |
Corporate headquarters Rockville, Maryland |
.
